Leanlife Health Inc.

As of December 31, 2021, Leanlife Health Inc. carries a market capitalization of 5.30M, placing it among publicly traded companies globally. Its enterprise value stands at 5.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2021, Leanlife Health Inc. has 207.11M shares outstanding.

These figures are as of December 31, 2021.

As of December 31, 2021, Leanlife Health Inc. maintains a current ratio of 0.52, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -20.71, indicating conservative leverage, while an interest coverage ratio of -330.31 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2021. Return on assets (ROA) is negative at -284.65, reflecting losses generated across the asset base.

As of the close on October 2, 2026, Leanlife Health Inc.'s stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.03.

Over the twelve months ended December 31, 2021, Leanlife Health Inc. generated - - in revenue and converted that into -2.81M in net income, yielding earnings per share of -0.01. EBITDA reached -2.81M, while operating income came in at -2.59M.

As of December 31, 2021, Leanlife Health Inc. holds 3,216.57 in cash and equivalents against 141,627.83 in total debt, resulting in a net debt position of 138,411.26. Total book value stands at -683,760.49, with working capital of -803,715.87 providing operational flexibility.

Leanlife Health Inc. produced -868,973.78 in operating cash flow over the twelve months ended December 31, 2021. After subtracting -115,043.88 in capital expenditures, free cash flow totaled -984,017.66 - equivalent to 0.00 per share.

These figures cover the twelve months ended December 31, 2021. Free cash flow yield is negative at -19.29: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -15.42, meaning Leanlife Health Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of December 31, 2021, Leanlife Health Inc. has an Altman Z-Score of -28.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.